SCENESSE

Cosmetic preparations for skin care, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; non-medicated sun tanning preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin, namely, cosmetics for tanning the skin based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and preparations for tanning without sunlight based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide

Pharmaceutical preparations, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, for skin care and for treating skin and skin relating conditions and disorders; medicated sun tanning preparations for pharmaceutical purposes, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; chemical and biological preparations, substances, reagents and compounds, namely, drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals which are based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and pharmaceutical preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, for use in dermatology, for skin care, for the treatment of skin disorders, for the protection of the dermis and epidermis used in the manufacture, delivery and storage of pharmaceuticals, drugs and diagnostic preparations